Shenlian Biotech announced that the pig foot-and-mouth disease type O, South African type 1 bivalent inactivated vaccine, and bovine and sheep foot-and-mouth disease type O, A, and South Africa type 1 trivalent inactivated vaccines produced by the Lanzhou branch of the company have obtained temporary approval documents for veterinary drug products issued by the Ministry of Agriculture and Rural Affairs. The product names of the vaccines are Taiyoulian and Taianlian respectively. The specifications are 20ml/bottle, 50ml/bottle, and 100ml/bottle, and are valid until July 19, 2028. The two products are genetically recombinant vaccines developed for currently popular strains. They can meet national epidemic prevention and control requirements, and are expected to enhance the company's market competitiveness.

Shenlian Biotech announced that the pig foot-and-mouth disease type O, South African type 1 bivalent inactivated vaccine, and bovine and sheep foot-and-mouth disease type O, A, and South Africa type 1 trivalent inactivated vaccines produced by the Lanzhou branch of the company have obtained temporary approval documents for veterinary drug products issued by the Ministry of Agriculture and Rural Affairs. The product names of the vaccines are Taiyoulian and Taianlian respectively. The specifications are 20ml/bottle, 50ml/bottle, and 100ml/bottle, and are valid until July 19, 2028. The two products are genetically recombinant vaccines developed for currently popular strains. They can meet national epidemic prevention and control requirements, and are expected to enhance the company's market competitiveness.